Interestingly, Nrf2 activated by sulforaphane was shown to suppress cardiac cell ferroptosis in both AGE-treated ECTs and the hearts of diabetic cardiomyopathy mice by upregulating ferritin and SLC7A11 [150]. Here, SLC7A11 is linked to diabetic cardiomyopathy.